EPISODE · Aug 22, 2025 · 26 MIN
Biomarkers, Genetics, and Anti-Amyloid Therapies for Early Stages of AD
from Keeping Current CME
Using biomarker testing and APOE genotyping to determine patient eligibility for amyloid-targeting therapies. Credit available for this activity expires: 8/19/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002844?ecd=bdc_podcast_libsyn_mscpedu
Embed this episode
NOW PLAYING
Biomarkers, Genetics, and Anti-Amyloid Therapies for Early Stages of AD
0:00
26:06
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Keeping Current CME?
This episode is 26 minutes long.
When was this Keeping Current CME episode published?
This episode was published on August 22, 2025.
Can I download this Keeping Current CME episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!